Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:606-609 (15 March), doi:10.1136/bmj.39503.424653.80
James C Milton, specialist registrar in geriatric and general medicine 1, Ian Hill-Smith, general practitioner2, Stephen H D Jackson, professor of clinical gerontology1
1 Clinical Age Research Unit, Department of Clinical Gerontology, Kings College Hospital Foundation Trust, London SE5 9PJ, 2 Stopsley Group Practice, Churchfield Medical Centre, Luton LU2 9SB
Correspondence to: J C Milton jim_milton@hotmail.com
| The first 150 words of the full text of this article appear below. |
|
About a fifth of the population in the United Kingdom is 60 years or older,1 yet people in this age group receive 59% of dispensed prescriptions and account for more than half of NHS drug costs.2 Older people often have several coexisting medical problems and take multiple drugs. Increasing age is associated with changes in pharmacokinetics and pharmacodynamics, so prescribing in this age group can be problematic.3
Many randomised controlled trials involving older patients focus on managing a single disease state, such as hypertension or osteoporosis, but
Quantitative indicators
Qualitative indicators
Evidence based indicators
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses